Clinical Characteristics and Outcomes of Toe Amputation Among Sudanese Diabetic Patients in Jabir Abu‐Eliz Diabetic Centre at Khartoum, 2021: A Cross Sectional Study Authors: ELsiddig ELzubair Ali Mohamed, Osman Amir, Mohammed ELmakki Ahmed, Abu Bakr Hassan Widatalla Published: 2026 ABSTRACT ABSTRACTBackgroundDiabetes mellitus (DM) causes a great majority of non‐traumatic major and minor amputations worldwide; up till now, this condition in developing countries, particularly those in sub‐Saharan Africa, including Sudan, is underestimated.AimTo determine the indications and outcomes of toe amputation among T2DM patients.MethodsA descriptive cross‐sectional study enrolled 100 patients with T2DM and DFU who had undergone toe amputation at Jabir Abu‐Eliz Diabetic Centre during the period from January to December 2021. Data regarding demographics, clinical characteristics, and outcomes were collected. SPSS v 26.0 software was used to analyze the data.ResultsAmong 100 patients, 63 (63%) were males, and 37 (37%) were females. The mean age was 61.3 ± 12.1 years. Wet gangrene was the main etiology (41%), and most of the cases underwent ray amputation (85%). Complete healing was reported in 65 (65%) patients, re‐ulceration in 17 (17%), re‐amputation in 9 (9%), and mortality in 9 (9%) patients. Re‐ulceration and death were common among the patients with peripheral arterial disease (PAD) (p value = 0.026) and longer DM duration above 10 years (p value < 0.001). Moreover, smoking was significantly associated with re‐amputation (p value = 0.044).ConclusionToe amputation was associated with males, older, hypertension, oral antidiabetic agents, poor glycemic control, and PAD. The majority of the cases had complete healing. Coexistence of PAD, longer DM duration above 10 years, and smoking were significantly correlated with worse outcomes.Keywords: diabetes mellitus, PAD, Sudan, toe amputation Abbreviations ankle brachial index diabetic foot ulcers diabetes mellitus glycosylated hemoglobin lower extremity amputations oral antidiabetic agents peripheral arterial disease types 1 diabetes mellitus types 2 diabetes mellitus Introduction Diabetes mellitus (DM) is a significant public health concern in Sudan, with an increasing prevalence that poses serious health risks, particularly in the form of diabetic foot complications. According to the World Health Organization, approximately 9.9% of the Sudanese population is affected by diabetes, predominantly type 2 diabetes. This condition is associated with various complications, including diabetic foot ulcers (DFUs), which can lead to substantial morbidity and the necessity for surgical interventions such as toe amputation. The incidence of lower extremity amputations (LEAs) among diabetic patients in Sudan is alarming; with studies indicating that around 17.1% of individuals with diabetes may require such procedures due to complications arising from DFUs [1]. The pathophysiology of DFUs involves a multifaceted interplay of factors, including neuropathy, peripheral vascular disease, and impaired wound healing. Neuropathy, a common complication of diabetes, results in loss of protective sensation in the feet, making patients unaware of injuries or ulcers. Peripheral vascular disease exacerbates the risk by reducing blood flow to the extremities, hindering healing, and increasing the likelihood of infection. In Sudan, the prevalence of DFUs is reported to be approximately 18.1%, underscoring the urgent need for improved management and prevention strategies [2]. Sociodemographic factors play a crucial role in the clinical characteristics of diabetic patients facing toe amputation. Research indicates that a significant proportion of patients undergoing LEA are male and over the age of 50, with many having lived with diabetes for over ten years. Comorbidities such as hypertension and retinopathy are also prevalent in this population, complicating their clinical management and increasing the risk of amputations. Furthermore, socioeconomic factors, including limited access to healthcare and education about diabetes management, contribute to poor outcomes and higher rates of amputations [3]. The surgical outcomes following toe amputation can vary widely among diabetic patients. Factors influencing these outcomes include the timing of the surgical intervention, the patient's overall health status, and the presence of comorbid conditions. Timely surgical intervention can significantly improve outcomes, yet many patients experience substantial morbidity following amputation, impacting their quality of life and independence. The socioeconomic implications of amputations are profound, as they can lead to increased healthcare costs and loss of productivity, placing additional burdens on families and the healthcare system [2]. The rising incidence of toe amputation among diabetic patients in Sudan highlights the urgent need for comprehensive strategies and studies aimed at prevention, early detection, and effective management of diabetic foot complications. Understanding the clinical characteristics and surgical outcomes of this population is essential for developing targeted interventions that can enhance patient care and reduce the burden of diabetes‐related amputations in Sudan. Thus, this study aims to characterize the clinical features and outcomes of toe amputations among Sudanese diabetic patients to improve patient outcomes. Methods Study Design and Subjects This prospective cross‐sectional study involved 100 patients diagnosed with type 2 DM (T2DM) and DFU who underwent toe amputation between January and December 2021. Inclusion criteria consisted of patients with confirmed diagnoses of T2DM and DFU who were scheduled for or had undergone minor amputation, specifically limited to the digital toe amputations, and who provided informed consent. For the purpose of this study, toe amputations were categorized as transphalangeal (partial or complete removal of the phalanx) or ray amputation (removal of the toe along with the corresponding metatarsal head). All procedures were performed by the surgical team at the Jabir Abu‐Eliz Diabetic Centre (JADC). Exclusion criteria included patients undergoing major lower extremity amputations (above or below the knee) or mid‐foot procedures (e.g., Lisfranc or Chopart) at the time of enrollment, individuals outside the designated study period and setting, and those with incomplete medical records. Study Area The study was conducted at the JADC in Khartoum State, which is the first multidisciplinary institution in Sudan dedicated to diabetes care. The center is equipped with consultation rooms for various specialists, including physicians, dietitians, and counselors, as well as facilities for laboratory work, pharmacy, operating theater, and a statistics and research unit. The primary objectives of the center are to provide specialized medical care for diabetic patients and to enhance public awareness regarding diabetes and its complications. Additionally, the center aims to serve as a training hub for medical and paramedical personnel in the field of diabetes. The center accommodates approximately 400 patients daily, with around half presenting with diabetic foot issues. It operates one shift from 8 a.m. to 4 p.m., staffed by 3−4 consultants each day, including specialists in general surgery, diabetic foot care, internal medicine, and ophthalmology, along with four general practitioners, a dietitian, and a psychologist. Methods Data were collected from patients who underwent toe amputation using a pre‐designed structured questionnaire. This questionnaire included demographic information (age and gender), medical history, duration of diabetes, diabetes medications, glycemic control assessed by HbA1c levels, and details regarding the toes and characteristics of the amputation. Peripheral arterial disease (PAD) was diagnosed based on specific criteria: (i) a non‐palpable pulse in the foot (either dorsalis pedis or posterior tibial); (ii) a lumen diameter reduction of more than 50%, as determined by Duplex Ultrasound; and (iii) an ankle/brachial index (ABI) of less than 0.9, measured using the BP‐203RPE model (Nihon Colin, Tokyo, Japan). The presence of any one of these criteria indicated a diagnosis of peripheral vascular disease. Also, the Wagner classification system for evaluating the progression of diabetic foot conditions was employed in this study. Diagnosis of osteomyelitis was based on probing to bone test with bone cultures for microbiological studies and/or repeated plain radiographic findings (Magnetic resonance imaging [MRI] and bone scintigraphy). Diabetic nephropathy (DN) diagnosis relies on detecting persistent albuminuria (microalbuminuria) and low eGFR (< 60 mL/min/1.73 m2) The outcomes evaluated following toe amputation included complete healing, re‐ulceration, the need for higher‐level amputations postoperatively, and mortality rates. Patients were followed postoperatively for a minimum period of 2 months to assess for the primary outcome of complete wound healing. This timeframe was selected to ensure adequate epithelial coverage and to monitor for early complications such as re‐ulceration or the need for revision. Statistical Analysis Data were initially entered into Microsoft Excel 2010 and subsequently analyzed using the Statistical Package for Social Sciences (SPSS; IBM, version 26.0). Results are presented as means and standard deviations (SD) for continuous variables, while categorical variables are expressed as numbers and percentages (%). The normality of the data was assessed using the Kolmogorov−Smirnov test. The Chi‐Square test was employed for significance testing, with a p value of less than 0.05 considered statistically significant (two‐sided). Ethical Approval Ethical approval was obtained from the National Research Ethics Review Committee in the Sudan Medical Specialization Board (SMSB). Also, approval for the study was obtained from the hospital authority. Patient data were anonymized by using identity numbers instead of names to protect individual identities, and the information was securely stored in a separate file. No references to individual participants were made in the study reports. Results In total, this study included 100 Sudanese diabetic patients, 63 (63%) were males, and 37 (37%) were females, their mean age was 61.3 ± 12.1 years, and 51 (51%) were aged above 60 years. The mean of DM duration was 13 ± 8 years, and the majority of the cases, 70 (70%), used oral antidiabetic agents (OADA). In glycemic control, most of the patients, 76 (76%), had HbA1c above 9%. PAD (ABI < 0.9) was found in 37 (37%) patients. The patient's characteristics were presented in Table 1. Table 1The baseline characteristics (N = 100). N %Age (year); mean ± SD61.3 ± 12.1 < 40 1313 40−60 3636 > 60 5151Gender Male 6363 Female 3737DM duration (years); mean ± SD13 ± 8 < 5 1515 5−10 3434 > 10 5151Medical history Hypertension 2525 Smoking 1414 Diabetic retinopathy 1313 Heart diseases 33 Diabetic nephropathy 22Medications OADA 7070 Insulin 2323 Modifying lifestyle 77Glycemic control (HbA1c) < 7% 66 7%−9% 1818 > 9% 7676ABI < 0.9 3737 0.91−1.2 4545 > 1.2 1818Abbreviations: ABI, ankle‐brachial index; DM, diabetes mellitus; HbA1c, glycosylated hemoglobin; OADA, oral antidiabetic agents. The baseline characteristics (N = 100). < 40 < 40 < 40 40−60 40−60 40−60 > 60 > 60 > 60 Male Male Male Female Female Female < 5 < 5 < 5 5−10 5−10 5−10 > 10 > 10 > 10 Hypertension Hypertension Hypertension Smoking Smoking Smoking Diabetic retinopathy Diabetic retinopathy Diabetic retinopathy Heart diseases Heart diseases Heart diseases Diabetic nephropathy Diabetic nephropathy Diabetic nephropathy OADA OADA OADA Insulin Insulin Insulin Modifying lifestyle Modifying lifestyle Modifying lifestyle < 7% < 7% < 7% 7%−9% 7%−9% 7%−9% > 9% > 9% > 9% < 0.9 < 0.9 < 0.9 0.91−1.2 0.91−1.2 0.91−1.2 > 1.2 > 1.2 > 1.2 Abbreviations: ABI, ankle‐brachial index; DM, diabetes mellitus; HbA1c, glycosylated hemoglobin; OADA, oral antidiabetic agents. Regarding to the toes and amputation characteristics, the majority of the patients had foot deformities (65%), first toe involvement (40%), wet gangrene etiology (41%), and underwent ray amputation (85%). Most of the cases in this study were Wagner grade‐3 (34%). Other characteristics are detailed in Table 2 Table 2The toes and amputation characteristics (N = 100). N %Foot deformities Hammer toe 1717 Pes cavus 1515 Crowded toe 1313 Pes planus 1010 Prominent metatarsal bones 66 Hallux valgus 33 Charcot joint 11Affected toe First 4040 Second 2626 Third 2121 Fourth 1717 Fifth 1919Causes of amputation Wet gangrene 4141 Osteomyelitis 3030 Abscess 2929Types of amputation Ray amputation 8484 Toe disarticulation 1616Wagner classification Grade 1 2222 Grade 2 2929 Grade 3 3434 Grade 4 1515 The toes and amputation characteristics (N = 100). Hammer toe Hammer toe Hammer toe Pes cavus Pes cavus Pes cavus Crowded toe Crowded toe Crowded toe Pes planus Pes planus Pes planus Prominent metatarsal bones Prominent metatarsal bones Prominent metatarsal bones Hallux valgus Hallux valgus Hallux valgus Charcot joint Charcot joint Charcot joint First First First Second Second Second Third Third Third Fourth Fourth Fourth Fifth Fifth Fifth Wet gangrene Wet gangrene Wet gangrene Osteomyelitis Osteomyelitis Osteomyelitis Abscess Abscess Abscess Ray amputation Ray amputation Ray amputation Toe disarticulation Toe disarticulation Toe disarticulation Grade 1 Grade 1 Grade 1 Grade 2 Grade 2 Grade 2 Grade 3 Grade 3 Grade 3 Grade 4 Grade 4 Grade 4 As shown in Figure 1 about two‐thirds of the subjects (65%) had complete healing; re‐ulceration was found in 17 (17%), re‐amputation in 9(9%), and mortality in 9 (9%) patients. The causes of death were related to diabetic septic foot (sepsis) in 3 (3%) patients, CVA‐related in 1 (1%), DM‐related complication (DKA) in 1 (1%), and sudden death in 4 (4%) patients. The re‐amputation cases primarily involved revision to a higher level of minor amputation (such as a ray resection following a failed transphalangeal procedure) or the involvement of adjacent toes. Notably, during the immediate follow‐up period, none of the patients required conversion to a major lower extremity amputation (above or below the knee). The outcomes of toes amputation (N = 100). Table 3 revealed that, significantly, re‐ulceration and death were common among the patients with PAD (p value = 0.026) and longer DM duration above 10 years (p value < 0.001). Moreover, smoking was significantly associated with re‐amputation (p value = 0.044). On the other hand, the amputation outcomes were not significantly affected by the age (p value = 0.578), gender (p value = 0.364), anti‐diabetic medications (p value = 0.876), coexistence of hypertension (p value = 0.756), diabetic retinopathy (p value = 0.570), heart diseases (p value = 0.890), and DN (p value = 0.627). Table 3The associations between selected patients characteristics and outcomes of toes amputation.HealingRe‐ulcerationRe‐amputationDeath p value n (%) n (%) n (%) n (%)Age (year) < 40 9 (69.2)3 (23.1)1 (7.7)0 (0)0.578a 40−60 20 (55.6)8 (22.2)3 (8.3)5 (13.9) > 60 36 (70.6)6 (11.8)5 (9.8)4 (7.8)Gender Male 43 (68.3)9 (14.3)7 (11.1)4 (6.3)0.364a Female 22 (59.5)8 (21.6)2 (5.4)5 (13.5)DM duration (years) < 5 13 (86.7)2 (13.3)0 (0)0 (0)< 0.001a , * 5−10 23 (67.6)5 (14.7)4 (11.8)2 (5.9) > 10 29 (56.9)10 (19.6)5 (9.8)7 (13.7)Medical history Hypertension 17 (26.2)5 (29.4)1 (11.1)2 (22.2)0.756a Smoking 8 (12.3)1 (5.9)4 (44.4)1 (11.1)0.044a Diabetic retinopathy 7 (10.8)4 (23.5)1 (11.1)1 (11.1)0.570a Heart diseases 0 (0)2 (11.8)0 (0)1 (11.1)0.890a Diabetic nephropathy 1 (1.5)1 (5.9)0 (0)0 (0)0.627a Medications OADA 44 (62.4)12 (17.1)8 (11.4)6 (8.6)0.876a Insulin 17 (73.9)4 (17.4)0 (0)2 (8.7) Modifying lifestyle 4 (57.1)1 (14.3)1 (14.3)1 (14.3)Glycemic control (HbA1c) < 7% 3 (50)1 (16.7)1 (16.7)1 (16.7)0.345a 7%−9% 9 (50)3 (16.7)2 (11.1)4 (22.2) > 9% 53 (69.7)13 (17.1)6 (7.6)4 (5.3)ABI < 0.9 21 (56.8)9 (24.3)5 (13.5)2 (5.4)0.026a , * 0.91−1.2 31 (68.9)4 (8.9)3 (6.7)7 (15.6) > 1.2 13 (72.2)4 (22.2)1 (5.6)0 (0)Abbreviations: ABI, ankle‐brachial index; DM, diabetes mellitus; HbA1c, glycosylated hemoglobin; OADA, oral antidiabetic agents. a Chi‐square test was used;* p value is significant (<0.05). The associations between selected patients characteristics and outcomes of toes amputation. < 40 < 40 < 40 40−60 40−60 40−60 > 60 > 60 > 60 Male Male Male Female Female Female < 5 < 5 < 5 5−10 5−10 5−10 > 10 > 10 > 10 Hypertension Hypertension Hypertension Smoking Smoking Smoking Diabetic retinopathy Diabetic retinopathy Diabetic retinopathy Heart diseases Heart diseases Heart diseases Diabetic nephropathy Diabetic nephropathy Diabetic nephropathy OADA OADA OADA Insulin Insulin Insulin Modifying lifestyle Modifying lifestyle Modifying lifestyle < 7% < 7% < 7% 7%−9% 7%−9% 7%−9% > 9% > 9% > 9% < 0.9 < 0.9 < 0.9 0.91−1.2 0.91−1.2 0.91−1.2 > 1.2 > 1.2 > 1.2 Abbreviations: ABI, ankle‐brachial index; DM, diabetes mellitus; HbA1c, glycosylated hemoglobin; OADA, oral antidiabetic agents. Chi‐square test was used; p value is significant (<0.05). Discussion In this study, the majority of the diabetic patients who had amputations were male. The study found that the males‐to‐females ratio was 1.7:1. This finding is in agreement with studies conducted by Sarfo‐Kantanka et al. [4], Lawrence S et al. [5], and Rodrigues et al [6]. Also, in a meta‐analysis by Lin et al. that included 21 studies reported male sex was associated with an increased risk of amputation (odds ratios [OR] = 1.30, 95% confidence interval (CI) = 1.16−1.46, p < 0.00001) [7]. In contrast, Sifiso et al. in South Africa [8] and Mohammad et al. in Iran [9] reported female predominance. The male preponderance in our study could be explained by the fact that men are more prone to be involved in outdoor activities like farming, construction work, and busy schedules compared to women. These activities, in addition to other lifestyle factors, such as smoking and alcohol consumption, might ultimately disturb their practice of foot care, consequential in amputation. This study showed amputation favored older patients, as most of our cases (51%) were aged above 60 years. This finding was supported by several studies performed in South Africa [8], Saudi Arabia [10], and Romania [11]. Sarfo‐Kantanka et al. reported that diabetes‐related amputation was associated with increased age at enrollment (for every 10 years increase in age: HR: 1.11, CI: 1.06–1.22, p < 0.001) [4]. In the current study, the mean of DM duration among amputees was 13 ± 8 years and the majority of our cohorts (51%) had DM duration above 10 years. Comparable figures were reported by Sudanese study of Alaa et al. where most of the subjects (48.2%) were had a duration of >10 years [12]. Also, our findings were supported by Moss et al. [13] and Lehto et al. [14] those reported longer duration of DM is a significant risk factor of amputation. In this study, regarding glycemic control, most of the amputees 76 (76%), had HbA1c above 9%. This is indicating that good glycemic control is essential for patients with DFU to prevent the progression of the disease and reduce the risk to be amputated. This finding was confirmed by Sarfo‐Kantanka et al. who reported that poor glycemic control is a significant predictor of diabetes‐related LLA (for a percent increase in HbA1c, HR:1.11, CI:1.05–1.25, p value = 0.03) [4]. Studies on the effect of glycemic control on amputation risk have been largely debatable. While a few authors have observed a significant association between the HbA1c and amputations [15, 16], others failed to show any significant association between HbA1C and LEA [17, 18]. This study illustrated that more than one‐thirds of patients (37%) who underwent amputation had PAD. Consistently, Ejiofor et al. the presence of PAD independently increased the probability of LEA by nearly threefolds (OR 2.8, 95% CI 1.520–5.110) [19]. Regarding to etiologies, wet gangrene was the major cause of amputation in our patients (41%), followed by osteomyelitis (30%) and abscess (29%). These findings were supported by the works of Sarfo‐Kantanka et al. [4], Lin et al. [7], and Ejiofor et al. [19] those identified gangrene as the leading cause of diabetes‐related LLA. In this study, re‐ulceration rate among our amputees was found to be 17%. In a systematic review of Rathnayake et al. the incidence of re‐ulceration ranged from 27.3%−40% [20]. Among our study group, the re‐amputation rate was 9%. This rate was comparable to the study of Chu et al. (12.5%) [21] but lower than Skoutas et al. and Izumi et al. which reported re‐amputation rates of 21.5% and 26.7%, respectively [22, 23]. In this study, the mortality rate was found to be 9%. This rate was similar to that reported by López‐Valverde et al. (9.4%) [24] and Ghanassia et al. (12%) [25], slightly higher than Chu et al. (5.8%) [21], lower than Faglia et al. (30%) [26] and Uzzaman et al. (15.6%) [27]. This variation in mortality rates might be attributed to several factors like differences in ethnicities, genetics, sample size, and sampling techniques. This study revealed that re‐ulceration and death were common among the patients with PAD (p value = 0.026) and longer DM duration above 10 years (p value < 0.001). Moreover, smoking was significantly associated with re‐amputation (p value = 0.044). These observations were in the same line with Chu et al. [21] and Nerone et al. [28]. Concerning clinical and policy implications, the findings advocate for urgent systemic interventions: Enhanced Glycemic Control: Prioritizing affordable access to insulin and OADA, alongside patient education on adherence. Early PAD Screening: Routine ABI measurements and Doppler studies in high‐risk patients to enable timely revascularization. Multidisciplinary Care Models: Establishing foot care teams to address infections, offloading, and smoking cessation, reducing preventable amputations. Postoperative Surveillance: Structured follow‐up protocols to monitor re‐ulceration and manage comorbidities. This study included several limitations that should be acknowledged, such as single‐center, relatively small sample size, a lack of socioeconomic status, and lack of long‐term follow‐up. Also, this study did not apply the WiFi score. Future multicenter, prospective studies with long‐term follow‐up are needed, as well as socioeconomic metrics be prioritized in future research. Despite these limitations, this study provides valuable insights into the indicators and outcomes of toe amputations among Sudanese patients with diabetes. Conclusion This study identified PAD, smoking, and long diabetes duration as significant risk factors for poor amputation outcomes. These findings underscore the importance of early detection, prevention, and comprehensive management of diabetic foot complications in the Sudanese healthcare system. Targeted interventions aimed at improving glycemic control, promoting foot care education, and addressing modifiable risk factors such as PAD and smoking may help reduce the burden of diabetic foot complications in Sudan. Author Contributions ELsiddig ELzubair Ali Mohamed: conceptualization, methodology, investigation, funding acquisition, visualization, project administration, resources, writing – original draft, writing – review and editing. Osman Amir: conceptualization, methodology, software, data curation, formal analysis, writing – review and editing, writing – original draft, investigation. Mohammed ELmakki Ahmed: conceptualization, methodology, investigation, supervision, funding acquisition, writing – review and editing, writing – original draft. Abu Bakr Hassan Widatalla: conceptualization, methodology, validation, investigation, visualization, resources, supervision, writing – review and editing, writing – original draft. Funding The authors have nothing to report. Ethics Statement Ethical approval was obtained from the center's ethical committee. Both verbal and written consents to publish this information were gained from the patients. Consent All authors gave their approval for publication. The authors certify that they have obtained all appropriate patient consent forms. Informed consent was obtained for participation. Conflicts of Interest The authors declare no conflicts of interest. Transparency Statement Eltype Lsiddig, the lead author, declares that this manuscript is honest, accurate, and transparent. He also clarifies that significant aspects of this study were not excluded, and any discrepancies from the planned study have been explicitly explained. Data Availability Statement The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. The data produced in this study can be obtained from the corresponding author upon reasonable request. References Associated Data Data Availability Statement The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. The data produced in this study can be obtained from the corresponding author upon reasonable request.